Rate of acquisition of staphylococcus, pseudomonas, and candida (per 10,000 exposure days) Ultra-clean Ordinary unit wards Coagulase-positive staphylococcus 7-3 60 Ps. aeruginosa 3-2 11 Candida albicans 6 30 ary ward were: 2 mixed chest infections, 2 urinary infections, 1 disseminated pseudomonas infection, and 2 bloodstream infections, one with Ps. aeruginosa and one with Candida albicans. Table 4 shows the rates of acquisition of various microbes by patients in the two types of ward environment.
Costs ofthe Unit A very relevant factor in discussing bacteriological surveillance of such complexity is the cost, which may be considered under a number of headings such as the cost of planning, building, and running the unit, the cost of additional specially trained staff required, and the cost of bacteriological and other investigations.
The capital cost per bed in this unit was approximately £5,500. The principal recurrent expenditure is on nurses' salaries. The nursing establishment is 22 for the 13 patients. There are additional but comparatively small costs attributable to air-conditioning plant and to central sterile supplies. So far as medical staff are concerned, the unit is part of a research unit, but the clinical team consisting of one consultant, one senior registrar and two senior house officers would seem to be the minimum to provide roundthe-clock care for 13 ultra-clean ward patients and a similar number of chemotherapy patients in open wards.
Although some of the running costs are attributable to the bacteriological surveillance of the ultra-clean unit, the same patients undergoing treatment in ordinary wards also require aboveaverage nursing care and bacteriological surveillance. Thus the additional running costs relate mainly to the nature of the clinical work undertaken and only to a limited extent to the operation ofthe ultra-clean unit itself.
The cost of laboratory investigations may be assessed by consideration of the work load related to the unit and ordinary ward chemotherapy patients. The load on the bacteriology laboratory in 1968 is shown in Table 5 . The 10,000 or so mixed specimens per year require the services, over and above the other laboratory staff, of two technicians, two part-time registrars, and approximately one weekly consultant session.
There is also a'considerable additional load on the hematology laboratory.
It is essential, before any commitment of this kind is undertaken, that the extra staff requirements, and the likely additional load of laboratory work, are properly assessed and provided for in advance.
Dr N F C Gowing (Department ofHistopathology, Royal Marsden Hospital, London S W3)
Morbid Anatomical and Histological Features of Unusual Infections
Infections occurring in patients with impaired immunity may be 'unusual' in at least three different ways: (1) There may be a simple numerical increase of rare infections in such patients, compared with the incidence in normal persons. (2) Common infections may take an unusually severe and/or widespread form, and the tissue reactions may be different from those seen in healthy people. (3) There may be a shift in the age distribution of certain infections when they occur in patients with impaired immunity. Two, or all three, of these unusual features may be combined in a given case.
'Opportunistic infections' is a term which has been used widely in recent years. At the Ciba Foundation Symposium on Systemic Mycoses (Wolstenholme & Porter 1968) opportunistic infections were defined as: 'Infections developing as a result of (a) the predisposing role of other diseases (particularly systemic disease of the lympho-reticular system, leukxemias, chronic anmmias and metabolic disorders); or (b) the use of therapeutic agents.' A very wide range of micro-organisms has been implicated: viruses, rickettsia, bacteria, fungi, protozoa, and even metazoal parasites such as Strongyloides stercoralis (Cruz et al. 1966 , Rogers & Nelson 1966 . Multiple infections are frequent. The influence of the geographical distribution of an infecting agent is sometimes apparent; for example, opportunistic infection by Coccidioides immitis has been reported in North America (Roberts et al. 1968 ). Virus infections: Common, normally nonfatal, virus infections may be severe and lethal in patients with impaired immunity. Fatal varicella has been reported in steroid-treated patients (Cheatham et al. 1956 , Haggerty & Eley 1956 ). However, varicella may run a benign course despite the administration of immunosuppressive agents. Fine et al. (1969) described the case ofa boy aged 8 years who contracted the infection while receiving azathioprine and steroids after renal homotransplantation. The varicella cleared up normally. Generalized herpes simplex infection complicating malignant lymphoma has been described by Lynfield et al. (1969) . Wright & Winer (1961) studied the incidence of herpes zoster in hospital patients. They found an incidence of 0-22 % in hospitalized patients with nonneoplastic disease, and 0-85 % in patients with malignant disease (of all types). The incidence of Hodgkin's disease and leukxemia was 9 % and 3 % respectively. Muller (1967) reported the association of zoster and malignant disorders in children. Smallpoxvaccination may proveto be a dangerous, indeed fatal, procedure for patients with depressed immunity; vaccinia gangrenosa, disseminated or generalized vaccinia may develop (Rosenbaum et al. 1966) . Fatal measles pneumonia (Hecht's pneumonia, giant cell pneumonia) usually affects children whose immunity is impaired; often there is no exanthem. Enders et al. (1959) and Mitus et al. (1959) showed that measles virus was the causative agent in giant cell pneumonia, and demonstrated the abnormally long persistence of the virus in the upper respiratory tract of the patients. Cytomegalic inclusion disease is a common infection, usually of little clinical significance. However, this virus may produce a fatal illness in patients with malignant disease of the lymphoreticular system (Fig 1) , or in those who have had a homotransplant operation followed by an immunosuppressive regime (Wong & Warner 1962 , Kanich & Craighead 1966 . It may be associated with infection by other organisms such as Pneumocystis carinii (Symmers 1960) .
Bacterial infections: Any species of pathogenic bacteria may be implicated, and organisms which normally cause relatively mild disease may produce overwhelming infection in immunosuppressed patients. Salmonella infection is sometimes very ominous in patients suffering from malignant disease of the hmmatopoietic system; 7 out of 16 such patients died in the series reported by Sinkovics & Smith (1969) . Listeria monocytogenes may also attack patients with this type of malignancy, as in the cases recorded by Louria et al. (1967) and by Buchner & Schneierson (1968) : meningitis, encephalitis, meningo-encephalitis or cerebral abscess may result. Similarly, more than half the 28 patients with Clostridium septicum infections reported by Alpern & Dowell (1969) had leuka:mia or malignant lymphoma.
In patients with myeloproliferative diseases, 'atypical' ('anonymous') mycobacteria may produce disseminated lesions or illness resembling malignant lymphoma, or may cause anemia or leukopenia (Kilbridge et al. 1967 , Zamorano & Tompsett 1968 . Mycobacterium tuberculosis may be the cause of fatal, widespread lesions in patients suffering from malignant lymphoma or leukxemia. Furthermore the lesions may be atypical in that the usual cellular response is minimal or absent, in which microscopy shows foci of caseation necrosis teeming with acid-fast bacilli, but no peripheral zone of epithelioid cells and Langhans' giant cells (Fig 2) . Another unusual tissue response to the tubercle bacillus has been described by Skinsnes (1968). The patient was an 8-year-old boy suffering from Hodgkin's disease; he developed tuberculosis, and the organisms were found in large numbers within histiocytes, the microscopic picture being reminiscent of lepromatous leprosy. Indeed, Skinsnes has suggested the term 'lepromatoid tuberculosis' for this variety of mycobacterial infection.
Protozoa: Toxoplasma gondii may cause severe foetal or neonatal disease, but clinical manifestations in older children and adults are usually mild. However, fatal generalized toxoplasmosis may occur in patients receiving immunosuppressive drugs after homotransplantation, or in those suffering from malignant disease of the lymphoreticular system (Reynolds et al. 1966 , Vietzke et al. 1968 , Barlotta et al. 1969 ). Vietzke et al. described extensive necrotizing encephalitis in patients developing toxoplasma infection secondary to malignant disease. Pneumocystis carinii causes pneumonia in premature infants, in infants with hypogammaglobulinmmia, and in children and adults whose immunologic state is depressed (Fig 3) . The exact nature of the organism is uncertain, but it is probably a protozoon (Barton & Campbell 1969) . There have been many reported instances of Pneumocystis carinii pneumonia affecting patients with neoplastic lymphoreticular disease (Esterly & Warner 1965 , Vogel et al. 1968 ). Very rarely, there is dissemination of the parasites to other organs, such as lymph nodes, spleen, liver and bone marrow (Jarnum et al. 1968 ). Fungus infections: Nocardia asteroides, although not a true fungus, is often considered under this heading. Nocardiosis is not uncommon in the United States, but it is rare in Britain; it may develop in patients suffering from severe anemia, leukemia or other malignant disease, and steroid administration may be a predisposing factor (Whitmore et al. 1961) .
According to Zimmerman (1955) the mycoses which are most likely to complicate other diseases, especially leukemias and lymphomas, are aspergillosis, candidiasis, cryptococcosis, histoplasmosis and mucormycosis. Furthermore, aspergillosis, candidiasis and mucormycosis are mainly responsible for the rising incidence of secondary mycoses following the introduction of modem chemotherapy. Keye mechanisms) was an important factor predisposing to secondary mycotic infection. Histoplasmosis, cryptococcosis, mucormycosis, candidiasis and aspergillosis all showed an increased incidence since 1947. Gruhn & Sanson (1963) , reviewing mycotic infections in leukmmic patients at autopsy, considered that an increased incidence of candidiasis and aspergillosis was causally associated with modem chemotherapy. Pillay et al. (1968) have reported fungus infections in 12 steroid-treated patients with systemic lupus erythematosus; Candida albicans was the fungus most commonly isolated. In this country, disseminated moniliasis complicating acute leukemia has been reported by Lannigan & Meynell (1959) . Histoplasmosis is a rare disease in Britain, but a case of disseminated histoplasmosis following long-term steroid therapy for reticulosarcoma has been recorded by Murray & Sladden (1965) . Cryptococcus neoformans may produce meningo-encephalitis in patients with Hodgkin's disease (Fig 4) or other conditions in which there is immunosuppression; a number of cases of disseminated cryptococcosis have been reported in Britain (Symmers 1953 , Gowing 1958 .
Occasionally, massive pulmonary consolidation may result from infection by cryptococci (Kent & Layton 1962 ). An excellent review of phycomycetous infection (mucormycosis) in cancer patients has been presented by Hutter (1959) who stressed the importance of therapy (and consequent depressed host resistance) in the pathogenesis of the disease. The main data concerning 13 consecutive cases of aspergillosis complicating malignant disease of the lymphoreticular system are shown in Table 1 . All these cases came to necropsy at the Royal Marsden Hospital. The tissue reactions seen in such cases have been described in detail elsewhere (Gowing & Hamlin 1960 , Symmers 1962 , and it will be noted that blood stream dissemination of the organism may produce lesions in many organs. The tissue response to the fungus may be either suppurative, with fungal abscesses containing greenish-yellow pus, or non-suppurative, characterized by spreading areas of coagulation necrosis (Figs 5 and 6 ). In the second type of reaction, the necrotic foci are opaque and yellowish and are surrounded by red zones of hyperwmia and hemorrhage. Such lesions are seen most frequently in the lungs; microscopically a small lesion consists of a central necrotic area containing branching fungal hyphe; the adjacent alveoli show hypertmia of their walls, and fibrinous exudate and hnmmorrhage into their lumina. The centrifugal spread of such a lesion and the fusion of neighbouring foci may result in the formation of a large necrotic mass. Alternatively, the fungus may invade tissue which is already necrotic, for example a pulmonary infarct. Sporing heads were seen in 2 of the 13 cases, and in one case fungal colonies displayed radiate formations with peripheral eosinophilic 'clubs' ('actinomycetoid' form, Moore 1946 
Complications of Bone Marrow Suppression
It is not easy to distinguish the complications of bone marrow suppression from those of immunosuppression. Most immunosuppressive agents also damage bone marrow cells. Whereas the main consequences of the latter are deficiencies of red cells, polymorphs and platelets, it must be remembered that the bone marrow is to a greater or lesser extent the source of stem cells for the lymphoid system (see Loutit 1968) and also for the body's macrophages (Pinkett et al. 1966) . A clear dissociation between the immunosuppressive and the myelosuppressive effect of drugs can sometimes be seen in cases of bone marrow hypoplasia or maturation arrest due to autoimmunity. Alone of the immunosuppressive agents steroid hormone is not myelotoxic. In the case shown in Fig 1 the addition of azathioprine , in appropriate dosage, actually enhanced the output of cells from the marrow, presumably by the removal of an autoimmune influence. L-asparaginase, which is a weak immunosuppressive agent, probably does not harm normal bone marrow cells, but antilymphocytic sera do have an anti-bone-marrow stem-cell effect. This is an important restriction to their use in bone marrow transplantation. All other immunosuppressive agents have a pronounced action on bone marrow cells. One reason for this coincidence is that both hmmopoiesis and specific immunization depend upon cell proliferation but this is not the whole story.
Hemorrhage is one of the outstanding complications of bone marrow suppression and is due to a lack of platelets. Concomitant liver damage may lead to a simultaneous lack of clotting factors, but this is uncommon. More important is the effect of local tissue damage or infection which, in the presence of moderate thrombocytopenia, may produce severe local hemorrhage. Such infections occur particularly in the alimentary tract. Another source of local tissue damage is the tumour which becomes necrotic following cytotoxic treatment. The newly formed vasculature gives way as a consequence of thrombocytopenia and local necrosis, and hemorrhage into multiple metastases or into a single cerebral deposit may have serious consequences.
It is possible also that the cytotoxic agents cause a significant degree of damage to the vascular endothelium. When bone marrow depression is prolonged there is a deficiency of polymorphs and probably also of macrophages, so that the resolution of ecchymoses in the tissues is prolonged. This is particularly conspicuous in the purpuric lesions which may persist in these patients without appreciable change for 
